<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>SLC1A3 treats glutamine deprivation — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>SLC1A3</strong>
  <span class="pred">&mdash;treats&rarr;</span>
  <strong>glutamine deprivation</strong>
</div>
<div class="entity-id">UNKNOWN:slc1a3 &nbsp;&middot;&nbsp; UNKNOWN:glutamine deprivation</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 109.50<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.0 (Physical) &times; log&#8322;(1+1) = 10.00<br>Incoming citations: 22 &rarr; score 109.50</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.26508/lsa.202201404">10.26508/lsa.202201404</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS4268">MTBLS4268</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 22 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:11px"></span><span>2</span><span class="cite-subtotal">&middot; +20.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">AspSnFR — is_biomarker_for → aspartate</span><span class="cite-claim-weight">+10.00</span><a href="../claim/9af8e237b7c7a853.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">aspartate — is_metabolite_of → malate-aspartate shuttle</span><span class="cite-claim-weight">+10.00</span><a href="../claim/6814967f05b2753e.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:100px"></span><span>18</span><span class="cite-subtotal">&middot; +83.20</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SLC6A14 — decreases → serine uptake</span><span class="cite-claim-weight">+0.40</span><a href="../claim/45c07f7a88e8ea60.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SLC25A15 — decreases → mitochondrial serine transport</span><span class="cite-claim-weight">+0.40</span><a href="../claim/e91824bf7fa3411c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">dual targeting of SLC6A14 and SLC25A15 — decreases → colorectal cancer cell growth</span><span class="cite-claim-weight">+0.40</span><a href="../claim/e1ed6e563055522c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">dual targeting of SLC6A14 and SLC12A4 — decreases → colorectal cancer cell growth</span><span class="cite-claim-weight">+0.40</span><a href="../claim/5189bbefa536b454.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">dual targeting of SLC6A14 and SLC25A15 — decreases → serine uptake</span><span class="cite-claim-weight">+0.40</span><a href="../claim/3d8f1e53e4b738b3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">dual targeting of SLC6A14 and SLC12A4 — decreases → serine uptake</span><span class="cite-claim-weight">+0.40</span><a href="../claim/ba409647d1ada7db.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SLC6A14 — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/b7ad32c1455178c5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">serine — activates → tumorigenesis</span><span class="cite-claim-weight">+0.40</span><a href="../claim/38c68c071aa6c5f8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glutamine — increases → aspartate</span><span class="cite-claim-weight">+8.00</span><a href="../claim/9fd6a40f6dda8ff3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">SLC25A12 — increases → aspartate export from mitochondria</span><span class="cite-claim-weight">+8.00</span><a href="../claim/d1dc442653c85b81.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Ca2+ signaling — activates → SLC25A12</span><span class="cite-claim-weight">+8.00</span><a href="../claim/e96143bebc44b3d6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">SLC25A12 — correlates_with → mitochondrial respiration</span><span class="cite-claim-weight">+8.00</span><a href="../claim/c79af4f0c67b4564.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">SLC45A4 — increases → intracellular polyamines</span><span class="cite-claim-weight">+8.00</span><a href="../claim/4d968368698b0d59.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">SLC overexpression panel (441 SLCs) — correlates_with → transcriptional profile</span><span class="cite-claim-weight">+8.00</span><a href="../claim/767b042f8a4425b5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">102 SLCs — correlates_with → known substrates</span><span class="cite-claim-weight">+8.00</span><a href="../claim/17a7b2372f8f0a5a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">71 unannotated SLCs — correlates_with → putative substrates or metabolic pathway connections</span><span class="cite-claim-weight">+8.00</span><a href="../claim/ab9d83a9a8c58696.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">functionally related SLC groups — correlates_with → osmolyte balancing</span><span class="cite-claim-weight">+8.00</span><a href="../claim/041551f6ecf0cfcd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">functionally related SLC groups — correlates_with → glycosylation</span><span class="cite-claim-weight">+8.00</span><a href="../claim/4e3b8b003102fa3b.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:11px"></span><span>2</span><span class="cite-subtotal">&middot; +6.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SLC12A4 — increases → serine uptake</span><span class="cite-claim-weight">+0.30</span><a href="../claim/907bc87a07b48dd3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">SLC overexpression panel (378 SLCs) — distinguishes → intracellular metabolite fingerprint (189 metabolites)</span><span class="cite-claim-weight">+6.00</span><a href="../claim/b44ee6817582b4cd.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>d81948ed5c38abaf</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:slc1a3">UNKNOWN:slc1a3</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/UNKNOWN:glutamine deprivation">UNKNOWN:glutamine deprivation</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
